• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Optimal design of mixed-effects PK/PD models based on differential equations.

作者信息

Wang Yi, Eskridge Kent M, Nadarajah Saralees

机构信息

Department of Statistics, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.

出版信息

J Biopharm Stat. 2012;22(1):180-205. doi: 10.1080/10543406.2010.513465.

DOI:10.1080/10543406.2010.513465
PMID:22204534
Abstract

There is a vast literature on the analysis of optimal design of nonlinear mixed-effects models (NLMMs) described by ordinary differential equations (ODEs) with analytic solution. However, much less has been published on the design of trials to fit such models with nonanalytic solution. In this article, we use the "direct" method to find parameter sensitivities, which are required during the optimization of models defined as ODEs, and apply them to find D-optimal designs for various specific situations relevant to population pharmacokinetic studies using a particular model with first-order absorption and elimination. In addition, we perform two simulation studies. The first one aims to show that the criterion computed from the development of the Fisher information matrix expression is a good measure to compare and optimize population designs, thus avoiding a large number of simulations; In the second one, a sensitivity analysis with respect to parameter misspecification allows us to compare the robustness of different population designs constructed in this article.

摘要

相似文献

1
Optimal design of mixed-effects PK/PD models based on differential equations.
J Biopharm Stat. 2012;22(1):180-205. doi: 10.1080/10543406.2010.513465.
2
Fisher information matrix for non-linear mixed-effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics.非线性混合效应模型的费舍尔信息矩阵:依诺肝素群体药代动力学优化设计的评估与应用
Stat Med. 2002 Sep 30;21(18):2623-39. doi: 10.1002/sim.1041.
3
Design evaluation and optimisation in crossover pharmacokinetic studies analysed by nonlinear mixed effects models.交叉药代动力学研究中通过非线性混合效应模型进行的设计评价与优化。
Stat Med. 2012 May 20;31(11-12):1043-58. doi: 10.1002/sim.4390. Epub 2011 Oct 3.
4
Comparison of robust criteria for D-optimal designs.D-最优设计的稳健准则比较
J Biopharm Stat. 2012;22(6):1193-205. doi: 10.1080/10543406.2011.580484.
5
Fisher information matrix for nonlinear mixed effects multiple response models: evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model.非线性混合效应多响应模型的费希尔信息矩阵:使用药代动力学/药效学模型评估一阶线性化的适用性
Stat Med. 2009 Jun 30;28(14):1940-56. doi: 10.1002/sim.3573.
6
Design evaluation and optimisation in multiple response nonlinear mixed effect models: PFIM 3.0.多响应非线性混合效应模型中的设计评估与优化:PFIM 3.0。
Comput Methods Programs Biomed. 2010 Apr;98(1):55-65. doi: 10.1016/j.cmpb.2009.09.012. Epub 2009 Nov 4.
7
Compound optimal design criteria for nonlinear models.非线性模型的复合最优设计准则
J Biopharm Stat. 2008;18(4):646-61. doi: 10.1080/10543400802071352.
8
A pragmatic approach to the design of population pharmacokinetic studies.一种用于群体药代动力学研究设计的实用方法。
AAPS J. 2005 Oct 5;7(2):E408-20. doi: 10.1208/aapsj070241.
9
Comparison of two design optimality criteria applied to a nonlinear model.应用于非线性模型的两种设计最优性准则的比较。
J Biopharm Stat. 2004 Nov;14(4):909-30. doi: 10.1081/BIP-200035458.
10
Robust designs in longitudinal studies accounting for parameter and model uncertainties - application to count data.纵向研究中考虑参数和模型不确定性的稳健设计——在计数数据中的应用。
J Biopharm Stat. 2020;30(1):31-45. doi: 10.1080/10543406.2019.1607367. Epub 2019 Apr 27.

引用本文的文献

1
Optimal design of perturbations for individual two-compartment pharmacokinetic analysis.用于个体二室药代动力学分析的扰动优化设计。
J Biopharm Stat. 2016;26(5):803-15. doi: 10.1080/10543406.2015.1074918. Epub 2015 Aug 6.